Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Utah Medical Products (UTMD) Current Deferred Tax Assets (2016)

Utah Medical Products has reported Current Deferred Tax Assets over the past 7 years, most recently at $393000.0 for Q4 2016.

  • Quarterly results put Current Deferred Tax Assets at $393000.0 for Q4 2016, up 8.26% from a year ago — trailing twelve months through Dec 2016 was $393000.0 (up 8.26% YoY), and the annual figure for FY2016 was $393000.0, up 8.26%.
  • Current Deferred Tax Assets for Q4 2016 was $393000.0 at Utah Medical Products, up from $363000.0 in the prior quarter.
  • Over the last five years, Current Deferred Tax Assets for UTMD hit a ceiling of $451000.0 in Q4 2012 and a floor of $303000.0 in Q4 2014.
  • Median Current Deferred Tax Assets over the past 5 years was $363000.0 (2015), compared with a mean of $367600.0.
  • Biggest five-year swings in Current Deferred Tax Assets: skyrocketed 35.44% in 2012 and later dropped 27.27% in 2013.
  • Utah Medical Products' Current Deferred Tax Assets stood at $451000.0 in 2012, then dropped by 27.27% to $328000.0 in 2013, then fell by 7.62% to $303000.0 in 2014, then grew by 19.8% to $363000.0 in 2015, then grew by 8.26% to $393000.0 in 2016.
  • The last three reported values for Current Deferred Tax Assets were $393000.0 (Q4 2016), $363000.0 (Q4 2015), and $303000.0 (Q4 2014) per Business Quant data.